Creotech Instruments S.A. engages in the manufacture and sale of satellites, satellite systems, and subsystems in Poland. The company offers satellites, such as Nano MR MS, Eagle HR MS, and Seagull HR SAR; platforms, including HyperSat Nano, HyperSat Eagle, and custom solutions; and various services comprising mission analysis and design, registration, insurance, launch, operations, data warehousing, processing, and advanced data analysis services. It also provides science products, such as Sinara/ARTIQ, MTCA/µTCA, White Rabbit by Creotech, standalone, FMC, and DI/OT, as well as controller, digital analog converter, analog digital converter, direct digital synthesizer, amplifier, delay, arbitrary waveform generator, digital input output, extension card, carrier, switch, PCIe board, and other products. In addition, the company offers CreoScan portable Ground Stations; Flight Monitoring System, a situational awareness system; Drone Rapid Mapping system, an integrated hardware and software solution; customized services; SAMPLE system which is used for the automated detection and monitoring of terrain obstacles; and Geomatic Remote Eye, a system which enables the collection of elevation data for given points or geographical areas. Further, it provides manufacturing services comprising full assembly for production of PCB, components, and blueprints; SMT and THT assembly; vacuum soldering; automatic optical and xray inspection; PCB cleaning; selective application of protective coatings; final assembly; press fit assembly; technical consulting and testing; traceability of individual devices from a batch; production of cable harnesses; and climatic research services. Creotech Instruments S.A. was founded in 2008 and is headquartered in Piaseczno, Poland.…
Wiadomości: Allegro, Diagnostyka, Creotech i Cyfrowy Polsat. Ważne informacje i dane ze spółek GPW
Creotech Instruments (WSE: CRI) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 297 employees.
The shares were at 658.00 PLN on 20 November 2026, up 68.7% over 52 weeks. Its 52-week range is 343.50 PLN to 1086.00 PLN: the price is 39.4% below the high and 91.6% above the low.
At a market capitalisation of 1.88B PLN, it trades at 108.6 times trailing earnings and 32.4 times forward earnings. The median trailing P/E of its 20 largest Aerospace & Defense peers is 30.8, a premium of 252% for CRI.
Creotech Instruments reports return on equity of 8.6%, an operating margin of 9.6% and revenue up 53.9% year over year.
It holds more cash than debt, a net cash position of 5.37M PLN. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 898.40 PLN is 36.5% above the current price.
No upcoming events tracked.